StreetAlpha.app
Home › Stocks › GMED

Globus Medical Inc (GMED)

Healthcare
$66.89
▼ −2.49%
LAST CLOSE · NOV 20

Globus Medical makes surgical implants and devices, including spinal products, used by surgeons. It last closed at $66.89 on Nov 20, down 2.49% on the day. The next earnings report for GMED is expected around Tue, Feb 23, 2027, after the close. For the quarter ended Sep 2026, GMED reported EPS of $1.04 on revenue of $763.7M, with revenue down 0.7% from a year ago. Over its last 8 reports the stock moved an average of 12.3% the session after earnings. Over the last 12 months GMED insiders bought $0 of stock on the open market and sold $16.0M, according to SEC Form 4 filings.

AI Auto Pilots
Is GMED in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GMED.

Key Stats

Last 12 months
Results
Revenue
$3.1B
+13.4% vs a year ago
Net income
$557.6M
+31.6% vs a year ago
EPS (diluted)
$4.06
+31.4% vs a year ago
Free cash flow
$766.5M
24.4% margin
Valuation
Market cap
$9.0B
134.3M shares
P/E
16.5
Price over 12 month EPS
Price to sales
2.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$441.3M
At Sep 30
Shareholder equity
$4.8B
Buybacks
$324.0M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $958.1M$958.1MFY2021FY2022: $1.0B$1.0BFY2022FY2023: $1.6B$1.6BFY2023FY2024: $2.5B$2.5BFY2024FY2025: $2.9B$2.9BFY2025

From GMED's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 23
Estimated date · After the close
Reported EPS
$1.04
Quarter ended Sep 2026
Year ago EPS
$0.88
+18.2% on a GAAP basis
Revenue
$763.7M
−0.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.19Dec '24Mar 2025: $0.54Mar '25Jun 2025: $1.49Jun '25Sep 2025: $0.88Sep '25Dec 2025: $1.02Dec '25Mar 2026: $0.90Mar '26Jun 2026: $1.10Jun '26Sep 2026: $1.04Sep '26Latest $1.04
Revenue by quarter
Dec 2024: $657.3MDec '24Mar 2025: $598.1MMar '25Jun 2025: $745.3MJun '25Sep 2025: $769.0MSep '25Dec 2025: $826.4MDec '25Mar 2026: $759.9MMar '26Jun 2026: $789.6MJun '26Sep 2026: $763.7MSep '26Latest $763.7M
How GMED moved after its last 8 reports
Average move the session after a report ±12.3%
Nov 5, 2026After the close−12.8%
Aug 6, 2026After the close+1.6%
May 7, 2026After the close−8.4%
Feb 24, 2026After the close+4.7%
Jan 7, 2026After the close+4.5%
Nov 6, 2025After the close+35.9%
Jul 21, 2025Time not announced−7.9%
May 8, 2025After the close−23.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on GMEDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on GMED
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on GMED

Technical Analysis

GMED · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 14% below its 20 day and 14% below its 50 day average. It is 23% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the 52 week low at $66.63, and the nearest resistance the Pivot at $67.69.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 4.7%/day
Key levels
$101.4052 week high+51.6%
$82.22200 day average+22.9%
$78.20100 day average+16.9%
$76.89Swing high (Sep 14)+14.9%
$76.0820 day average+13.7%
$75.9750 day average+13.6%
$68.74Pivot R1+2.8%
$67.69Pivot+1.2%
$66.89Last close
$66.6352 week low−0.4%
$65.83Pivot S1−1.6%
Indicators
RSI (14)35.16Weak, oversold below 30Neutral
MACD-2.53Below its signal lineBearish
Stochastic3.6Near the bottom of its rangeOversold
ADX (14)21.9Weak trend
Williams %R-98.8Oversold below −80, overbought above −20Oversold
CCI (20)-123.2Oversold below −100, overbought above 100Oversold
Rate of change−5.9%Change over 10 sessionsBearish
ATR (14)$3.11Typical daily range, 4.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for GMED

What happened before

See how GMED did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow GMED usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How GMED has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for GMEDHow many large options trades hit GMED, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

GMED Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲320 buying vs 260 selling
  • ●Held by funds +0.1 pts
  • ▲Funds holding +15
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding617602+2.5%
In funds' top 1011110.0%
Held by funds89.0%88.9%+0.1 pts
New / increased88 / 23275 / 251−1.8%
Reduced / sold out191 / 69178 / 88−2.3%
Put/call ratio2.160.11+1910.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See GMED institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

GMED Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$16.0M12 sales · 7 insiders
40% of the selling was under pre-arranged trading plans.
2025-12 sold $2.0M2026-01 sold $566K2026-02 sold $2.8M2026-06 sold $2.0M2026-08 sold $2.2M2026-09 sold $2.2M2026-11 sold $3.6MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 10James R TobinDirectorSale41,666$75.16$3.1M
Nov 4Ann D RhoadsDirectorSale plan5,000$85.00$425K
Sep 15James R TobinDirectorSale30,000$74.58$2.2M
Aug 18Stephen T ZarrilliDirectorSale25,000$87.04$2.2M
Jun 5David D DavidarDirectorSale25,000$80.76$2.0M
Feb 25Kelly HullerEVP, GC, Corporate SecretarySale plan20,000$94.50$1.9M
Every insider buy and sale for GMED over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See GMED insider trades →

From SEC Form 4 filings by GMED's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GMED is in one of them and how their past GMED trades turned out.

GMED in the AI portfolios
Loading…

GMED News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered GMED in an article yet. Here's the latest on the wider market.

GMED in the news

GMED Congress Trades

All congress trades →
Trades, 12 months
3
Buys
3
100%
Sells
0
0%
People
1
Last filed Oct 12
Who traded GMED · since 2015
Latest 5 filings of 22
$1K – $15KTraded Sep 3, 2026Filed Oct 12, 2026
$15K – $50KTraded Aug 19, 2026Filed Sep 10, 2026
$1K – $15KTraded Mar 3, 2026Filed Apr 7, 2026
$1K – $15KTraded Jul 10, 2025Filed Aug 13, 2025
Lisa McClainSell (partial)
$1K – $15KTraded Jun 24, 2025Filed Aug 13, 2025
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KSep 3, 2026Oct 12, 202639 d
Gilbert CisnerosD · CABuy$15K – $50KAug 19, 2026Sep 10, 202622 d
Gilbert CisnerosD · CABuy$1K – $15KMar 3, 2026Apr 7, 202635 d
Lisa McClainR · MISell$1K – $15KJul 10, 2025Aug 13, 202534 d
Lisa McClainR · MISell (partial)$1K – $15KJun 24, 2025Aug 13, 202550 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Globus Medical

Globus Medical is a medical device company based in Audubon, Pennsylvania. It makes surgical implants and devices, including spinal products such as cervical artificial discs, spinal cord stimulation systems, and a scoliosis correction system, along with human tissue products used in surgery. Its products are used by surgeons in the United States and in other countries, and each must meet the rules of the regulators where it is sold.

Headquarters
Audubon, PA
Founded
2003